The Paul-Ehrlich-Institute (PEI) in Germany has granted approval to continue subject enrolment in cohort 5 of Oncolytics ...

Innovent Biologics receives China NMPA breakthrough therapy designation for IBI343 as monotherapy for advanced pancreatic cancer: San Francisco, US Friday, January 17, 2025, 09:00 ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...